HOME › Research Insight › Product Approvals is the Key Strategy Adopted by Leading Market Players to Foster Growth in the Global Sepsis Diagnostics Market
Product Approvals is the Key Strategy Adopted by Leading Market Players to Foster Growth in the Global Sepsis Diagnostics Market
The global sepsis diagnostics market was dominated by bioMérieux SA (France) and Becton, Dickinson and Company (U.S.) in 2015. With its broad product portfolio, bioMérieux SA held the leadership position in the global sepsis diagnostics market in 2015. bioMérieux portfolio includes a wide range of product categories, namely, blood culture kits, blood culture identification panels, procalcitonin immunoassays, and microbial identification/antimicrobial resistance testing. The company has received approval for a number of products such as the VIDAS B.R.A.H.M.S PCT (Procalcitonin) assay, VIDAS 3 system, VIRTUO system, and FilmArray 2.0 system, with the aim to offer enhanced sepsis diagnostic solutions for better patient care. Over the past three years, the company adopted the strategies of partnership; product approval; and acquisitions to maintain its leadership position in the global sepsis diagnostics market.
Becton, Dickinson and Company (U.S.) held the second position in the sepsis diagnostics market in 2015. The company has a robust portfolio of products in various categories, such as, safety-engineered blood collection products and systems, automated blood culturing systems, microorganism identification and drug susceptibility systems, molecular testing systems for infectious diseases and women’s health, rapid diagnostic assays, microbiology laboratory automation and plated media, and integrated systems for specimen collection, among others. The company has wide geographical presence across the North America, Europe, Asia-Pacific, Middle East, and Africa. Over the past three years, the company has also received approval for its sepsis diagnostic products, which have helped the company launch new products in the global sepsis diagnostics market.
In the sepsis diagnostics market, leading players are adopting the strategies of new product launches, product approvals, agreements, partnerships, collaborations, and acquisitions in order to increase their market share. Market players adopted these strategies to access new technologies, develop novel products, expand their product portfolio and distribution network, and enter into growing markets. Leading players are also focusing towards increasing their market visibility and strengthening their research and development capacities. In addition to the above stated top two market players, companies such as T2 Biosystems, Inc. (U.S.), Cepheid (U.S.), Thermo Fisher Scientific Inc. (U.S.), Nanosphere, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Bruker Corporation (U.S.), and Beckman Coulter, Inc. (U.S.) are primarily focused towards launching new products, collaborations, and acquisitions in order to strengthen their footprint in the sepsis diagnostics market.
Sepsis Diagnostics Market by Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) - Global Forecast to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India